Hydroxyzine: Adverse effects alleviated by change in dosage regimen: clinical studyHydroxyzine, pharmacodynamicsTerfenadine, pharmacodynamicsReactions Weekly
While the adverse effects of patient nonadherence on the therapeutic benefits of drug therapies have been increasingly recognized,34 the effect of nonadherence on the risk of adverse drug events has not been widely considered. As patient education is an essential component of most efforts to improve...
Adverse events and adverse drug reactions are common in clinical practice. Side effects range from the common to the rare and may be confused with other mucocutaneous manifestations resulting from several medications to treat infections, other medical conditions, and in the clinical setting of oncologic...
SIDE EFFECTS: Nausea, stomach upset, cramps, loss of appetite, diarrhea, dry mouth, headache, nervousness, dizziness, trouble sleeping, sweating, weight loss, irritability, and restlessness may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.Remember tha...
SIDE EFFECTS:Nausea/vomiting, stomach/abdominal pain, headache, trouble sleeping, diarrhea, irritability, restlessness, nervousness, shaking, or increased urination may occur. If any of these effects last or get worse, tell your doctor or pharmacist promptly.Remember that this medication has been pre...
Kardaun S, Sidoroff A, Valleyrie-Allanore L et al (2007) Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156:609–612 PubMedCASGoogle Scholar ...
the endpoint of titration is achievement of adequate pain relief, balanced against tolerability of opioid side effects; if a patient develops intolerable opioid related side effects, the methadone dose, or dosing interval, may need to be decreased; for patients on a regimen of fixed-ratio opioid/...
The oral sphingosine-1-phosphate receptor modulator fingolimod (FTY720) was recently approved for the treatment of relapsing-remitting multiple sclerosis. To date, data about a possible recurrence of disease activity after discontinuation of fingolimod treatment are scarce.To describe a patient who ...
USES: This medication is used to treat women who have not gone through menopause who have low sexual desire and are concerned about it.Flibanserin should not be used to treat low sexual desire caused by: a medical or mental/mood disorder, problems in the relationship, or the effects of othe...
This disclosure relates to treatments for reducing the side effects associated with treatment of a medication or drug, such as a chemotherapy medication, being experienced by a pati